NEW YORK (GenomeWeb) – Singapore-based company Carmentix Private Limited and Australia's University of Melbourne announced a new initiative last week to discover biomarkers related to preterm birth.

"Carmentix is excited to begin this collaboration, as we are keen to further develop the biomarkers discovered on our unique data mining platform," CEO Nir Arbel said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.